Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2004
03/18/2004WO2003066595A3 2 - piperazine - pyridines useful for treating pain
03/18/2004WO2003035615A3 Tyrosine kinase inhibitors
03/18/2004US20040054195 Fluorescent dyes; photostability; labels, staining; analysis
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040054185 Antihistamines; cardiovascular disorders; cognition activators; Alzheimer's disease
03/18/2004US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents
03/18/2004US20040054177 Novel benzimidazole derivatives
03/18/2004US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity
03/18/2004US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer
03/18/2004US20040053965 N-type calcium channel antagonists for the treatment of pain
03/18/2004US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053952 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
03/18/2004US20040053951 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use
03/18/2004US20040053943 Novel compounds
03/18/2004US20040053937 Pyrimidine compounds
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053928 Quinoline derivatives as antibacterials
03/18/2004US20040053926 Triazine compounds
03/18/2004US20040053914 Substituted piperzino-pyridine compound, useful for treting pain, anxiety, urinary incontinence, an addictive disorder, Parkinson's disease, epilepsy, psychosis, and used as Selective antagonists of the metabotropic glutamate receptor 5
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/18/2004US20040052981 Ink jet recording material
03/18/2004DE10242350A1 New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis
03/18/2004CA2501924A1 Non-nucleoside reverse transcriptase inhibitors
03/18/2004CA2497901A1 Furan or thiophene derivative and medicinal use thereof
03/17/2004EP1398166A1 Ink jet recording material and light-stabilising agent
03/17/2004EP1398032A1 4-Oxo-quinazolines as LXR nuclear receptor binding compounds
03/17/2004EP1398029A1 NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
03/17/2004EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
03/17/2004EP1397361A1 Carboline derivatives as pdev inhibitors
03/17/2004EP1397357A2 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
03/17/2004EP1397350A1 Isoquinolinone derivatives as parp inhibitors
03/17/2004EP1397341A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
03/17/2004EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
03/17/2004EP1354020A4 Novel red fluorescent material and organic electroluminescent device containing same
03/17/2004EP1246816B1 Substituted phenyl-piperazine derivatives, their preparation and use
03/17/2004EP1246815B1 Phenylpiperazinyl derivatives
03/17/2004EP1242406B1 Novel compounds
03/17/2004EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
03/17/2004EP1140839B1 Heterocyclic amides as inhibitors of factor xa
03/17/2004EP1140820B1 New amidino derivatives and their use as thrombin inhibitors
03/17/2004EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
03/17/2004EP1137644B9 Benzofuran derivatives, their preparation and use
03/17/2004EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
03/17/2004EP0891332B1 6-phenylpyridyl-2-amine derivatives
03/17/2004CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders
03/17/2004CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors
03/17/2004CN1142174C Optical information gene material and its application in gene chip technology
03/17/2004CN1142161C Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists
03/17/2004CN1142160C Mold inhibitor and its prepn. and agricultural and forestry disease preventing and controlling germicide thereby
03/16/2004US6706882 Process for the preparation of (pyridinylidene)-phthalides
03/16/2004US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands
03/16/2004US6706754 Antiprotozoa agents, parasiticides
03/16/2004US6706753 Integrin receptor inhibitors
03/16/2004US6706740 Controlling, prevention fungi infections
03/16/2004US6706739 Treating enterovirus infection
03/16/2004US6706731 With isoquinoline derivatives as antitumor agents
03/16/2004US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
03/16/2004US6706712 Cyclic derivatives as modulators of chemokine receptor activity
03/16/2004US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc.
03/16/2004US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/16/2004US6706254 Cyanine dye bioconjugates useful for diagnostic imaging and therapy
03/11/2004WO2004020435A1 Piperidinyl compounds that selectively bind integrins
03/11/2004WO2004020434A1 Azaarene derivatives
03/11/2004WO2004020432A1 Arylamides
03/11/2004WO2004020431A2 Novel benzoimidazole derivatives useful as antiproliferative agents
03/11/2004WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
03/11/2004WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
03/11/2004WO2004020414A1 Oxytocin inhibitors
03/11/2004WO2004020412A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
03/11/2004WO2004020410A2 Dihydropyridinone derivatives as hne inhibitors
03/11/2004WO2004020409A1 Indoles having anti-diabetic activity
03/11/2004WO2004020408A1 Indoles having anti-diabetic activity
03/11/2004WO2004019943A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/11/2004WO2004005279A3 Substituted anthranilic amide derivatives and methods of use
03/11/2004WO2004004699A3 Use of dantrolene, a ryanodine antagonist, in treating neural injury
03/11/2004WO2003078420A3 Process for making chiral 1,4-disubstituted piperazines
03/11/2004WO2003006444A3 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
03/11/2004WO2002076404A3 Fatty alcohol drug conjugates
03/11/2004US20040049046 Small molecule inhibitors of rotamase enzyme activity
03/11/2004US20040049043 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
03/11/2004US20040049036 From diphenyl (4-(4-fluorophenyl)-6-isopropyl-2-(methyl-(methyl sulfonyl)amino)pyrimidin-5-ylmethyl)phosphine and tert-butyl-2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl) acetate; removal of tert-butyl group to form acid or salt
03/11/2004US20040049035 Pyrrolecarboxamides and pyrrolethioamides as fungicides
03/11/2004US20040049008 Templated molecules and methods for using such molecules
03/11/2004US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
03/11/2004US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
03/11/2004US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc.
03/11/2004US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
03/11/2004US20040048881 Quinazoline derivatives with anti-tumour activity
03/11/2004US20040048880 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
03/11/2004US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
03/11/2004US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics.
03/11/2004US20040048868 Benzimidazoles
03/11/2004US20040048866 3-substituted with an oxy-, thio- or amino- group; increasing cGMP levels
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/11/2004US20040048863 Treating osteoarthritis or rheumatoid arthritis
03/11/2004US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/11/2004US20040048848 Novel gamma secretase inhibitors